Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7
Abstract Background Adherence to clinical practice guidelines for coronary heart disease (CHD) reduces morbidity, mortality and treatment costs. We aimed to describe and compare adherence to prescription guidelines for persons with CHD, and explore its association with treatment goal achievement. Me...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article in Journal/Newspaper |
| Language: | unknown |
| Published: |
figshare
2021
|
| Subjects: | |
| Online Access: | https://dx.doi.org/10.6084/m9.figshare.c.5278087 https://springernature.figshare.com/collections/Adherence_to_prescription_guidelines_and_achievement_of_treatment_goals_among_persons_with_coronary_heart_disease_in_Troms_7/5278087 |
| Summary: | Abstract Background Adherence to clinical practice guidelines for coronary heart disease (CHD) reduces morbidity, mortality and treatment costs. We aimed to describe and compare adherence to prescription guidelines for persons with CHD, and explore its association with treatment goal achievement. Method We included all participants reporting myocardial infarction, angina, percutaneous coronary intervention and/or coronary artery bypass surgery in the seventh wave of the Tromsø Study (2015–2016, n = 1483). Medication use and treatment goal measures (blood pressure, low-density lipoprotein (LDL)-cholesterol and HbA1c) were compared to clinical practice guidelines on secondary CHD prevention. Propensity score matched logistic regression was used to assess the association between the use of antihypertensive drugs and achievement of treatment goal for blood pressure, and the use of lipid-lowering drugs (LLDs) and achievement of treatment goal for LDL-cholesterol. Results The prevalence of pharmacological CHD treatment was 76% for LLDs, 72% for antihypertensive drugs and 66% for acetylsalicylic acid. The blood pressure goal ( |
|---|